Simplex Trading, LLC Glycomimetics Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$2.55 - $3.49 $46,427 - $63,542	18,207 Added 25.13%	90,652 $271,000
Q4 2023 Feb 02, 2024	BUY	$1.13 - $2.54 $81,862 - $184,010	72,445 New	72,445 $170,000
Q2 2023 Aug 04, 2023	BUY	$1.21 - $2.08 $22,191 - $38,147	18,340 New	18,340 $31,000
Q4 2022 Feb 02, 2023	BUY	$0.57 - $3.03 $37,270 - $198,119	65,386 Added 2997.98%	67,567 $204,000
Q3 2022 Nov 04, 2022	BUY	$0.55 - $0.9 $1,194 - $1,953	2,171 Added 21710.0%	2,181 $1,000
Q2 2022 Aug 03, 2022	SELL	$0.54 - $1.15 $2,218 - $4,725	-4,109 Reduced 99.76%	10 $0
Q1 2022 May 02, 2022	SELL	$1.0 - $1.58 $95,183 - $150,389	-95,183 Reduced 95.85%	4,119 $4,000
Q4 2021 Feb 23, 2022	BUY	$1.44 - $2.14 $142,994 - $212,506	99,302 New	99,302 $142,000
Q2 2021 Aug 12, 2021	SELL	$2.16 - $3.18 $8,043 - $11,842	-3,724 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$2.89 - $4.22 $10,184 - $14,871	3,524 Added 1762.0%	3,724 $11,000
Q4 2020 Feb 02, 2021	SELL	$2.69 - $4.24 $19,666 - $30,998	-7,311 Reduced 97.34%	200 $0
Q3 2020 Oct 14, 2020	BUY	$3.07 - $5.0 $104 - $170	34 Added 0.45%	7,511 $23,000
Q2 2020 Jul 13, 2020	BUY	$2.06 - $3.76 $12,434 - $22,695	6,036 Added 418.88%	7,477 $28,000
Q1 2020 Apr 29, 2020	BUY	$1.83 - $5.41 $2,637 - $7,795	1,441 New	1,441 $3,000
Q3 2019 Oct 15, 2019	SELL	$2.8 - $12.85 $6,462 - $29,657	-2,308 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$10.6 - $13.12 $214,035 - $264,919	-20,192 Reduced 89.74%	2,308 $27,000
Q1 2019 Apr 18, 2019	BUY	$9.96 - $13.44 $180,475 - $243,532	18,120 Added 413.7%	22,500 $0
Q4 2018 Jan 16, 2019	BUY	$8.47 - $14.71 $37,098 - $64,429	4,380 New	4,380 $41,000
Q3 2018 Oct 23, 2018	SELL	$13.7 - $17.12 $11,302 - $14,124	-825 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$14.63 - $19.19 $18,404 - $24,141	-1,258 Reduced 60.39%	825 $13,000
Q1 2018 Apr 26, 2018	SELL	$16.06 - $25.35 $46,927 - $74,072	-2,922 Reduced 58.38%	2,083 $33,000
Q4 2017 Jan 10, 2018	SELL	$10.51 - $17.22 $95,809 - $156,977	-9,116 Reduced 64.56%	5,005 $84,000
Q3 2017 Oct 25, 2017	BUY	$10.14 - $14.85 $143,186 - $209,696	14,121	14,121 $197,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

25.6M

Call Options Held

1.94M

Put Options Held

153K

Bvf Inc San Francisco, CA

9.54M
Shares

$1.62 Million
0.08% of portfolio
Artal Group S.A. Luxembourg, N4

8.59M
Shares

$1.46 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

2.7M
Shares

$458,474
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

827K
Shares

$140,564
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

804K
Shares

$136,738
0.0% of portfolio

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $8.91M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account